Verona Pharma plc
VRNADelisted Oct 7, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001657312
Verona Pharma plc was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 243 institutions reported holding it in 13F filings for Q3 2025, worth $8.57B in total; superinvestors Duquesne Family Office and Soros Fund Management held it.
13F holders, Q1 2023
Institutional positions in Verona Pharma plc as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 95
- +9 vs. Q4 2022
- Shares held
- 60.4M
- +8.54M (+16.5%) vs. Q4 2022
- Total value
- $1.21B
- −$36.1M (−2.9%) vs. Q4 2022
- New holders
- 22
- 39 more added
- Sold out
- 13
- 21 more reduced
2 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VRNA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $359.0K |
| Q3 2025 | 243 | $8.57B |
| Q2 2025 | 292 | $7.18B |
| Q1 2025 | 258 | $4.58B |
| Q4 2024 | 191 | $3.19B |
| Q3 2024 | 150 | $1.95B |
| Q2 2024 | 125 | $957.0M |
| Q1 2024 | 113 | $1.08B |
| Q4 2023 | 117 | $1.35B |
| Q3 2023 | 102 | $1.07B |
| Q2 2023 | 105 | $1.33B |
| Q1 2023 | 95 | $1.21B |
| Q4 2022 | 88 | $1.31B |
| Q3 2022 | 68 | $529.0M |
| Q2 2022 | 40 | $145.9M |
| Q1 2022 | 39 | $181.7M |
| Q4 2021 | 42 | $248.0M |
| Q3 2021 | 40 | $202.7M |
| Q2 2021 | 37 | $239.9M |
| Q1 2021 | 37 | $305.1M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Verona Pharma plc; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −19,300−100.0% | Sold out |
| Truist Financial Corp | 0 | $0 | 0.00% | −11,600−100.0% | Sold out |
| HSBC Holdings PLC | 0 | $0 | 0.00% | −10,041−100.0% | Sold out |
| Rathbone Brothers plc | 0 | $0 | 0.00% | −9,709−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −9,081−100.0% | Sold out |
| Northeast Financial Consultants Inc | 0 | $0 | 0.00% | −8,700−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −8,686−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −860−100.0% | Sold out |
| Abingworth LLP | – | – | – | – | Not filed |
| CoreCap Advisors, LLC | – | – | – | – | Not filed |